Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: A cochrane meta-analysis

Gastroenterology

Volumn 124, Issue 5, 2003, Pages 1277-1291

  D'Amico, Gennaro ^a   Pietrosi, Giada ^a   Tarantino, Ilaria ^a   Pagliaro, Luigi ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EMBASE; EMERGENCY TREATMENT; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; INTERMETHOD COMPARISON; LIMB ISCHEMIA; LIVER CIRRHOSIS; MALE; MEDLINE; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SEIZURE;

EID: 0038297513     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00269-5     Document Type: Article

References (64)

1. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081-1091.
2. Goulis J, Burroughs AK. Portal hypertensive bleeding: prevention and treatment, In: McDonald J, Burroughs AK, Feagan B, eds, Evidence-based gastroenterology and hepatology. London: BMJ, 1999:389-426.
3. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension. A meta-analytic review. Hepatology 1995;22:332-354.
4. de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999;19:439-455.
5. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, Salcedo M, Molinero LM. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002;35:609-615.
6. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients, Cochrane Database Syst Rev. 2002;1:CD002233.
7. ICHGCP. Barnett International-Clinical training group. Code of federal regulation and ICH guidelines. Volume 1. Parexel/Barnett, 1997.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay DM. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
9. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
10. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982-989.
11. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance not choice. Lancet 2002;359:515-519.
12. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-618.
13. Schultz KF, Grimes AD. Blinding in randomised trials. Lancet 2002;359:696-700.
14. Schultz KF, Grimes AD. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002;359:781-785.
15. Burroughs AK. Methodology and review of clinical trials in portal hypertension, Amsterdam ed.: Excerpta Medica, 1987.
16. Grace N, Groszman RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann G, Henderson MJ, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-880.
17. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
18. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-1060.
19. Garcia-Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Semin Liver Dis 1999;19:427-437.
20. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence based approach. Semin Liver Dis 1999;19:475-506.
21. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Review. The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
22. Gøtzsche PC. Somatostatin or octreotide for acute bleeding oesophageal varices. The Cochrane Library, Issue 1, 1999. Oxford. Update Software.
23. Burroughs AK, McCormick A, Hughes MD, Sprengers D, D'Heygere F, McIntyre N. Randomized double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990;99:1388-1395.
24. Burroughs AK. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures. Hepatology 1996;24(suppl):352A (abstr).
25. Imperiale T, Teran C, McCullough AJ. A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 1995;109:1289- 1294.
26. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
27. Laupacis A, Sackett DL, Roberts AS. An assessment of clinically useful mesaures of the consequences of treatment. N Engl J Med 1988;318:1728-1733.
28. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-1312.
29. Escorsell A, Bordas JM, del Arbol LR, Jaramillo JL, Planas R, Banares R, Albillos A, Bosch J. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. J Hepatol 1998;29:779-788.
30. Begg CB, Mazumadar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088- 1098.
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-634.
32. Soderlund C, Ihre T. Endoscopic sclerotherapy vs conservative management of bleeding esophageal varices. Acta Chir Scand 1985;151:449-456.
33. Larson AW, Cohen H, Zwieiban B, Chapman D, Gourdji M, Korula J, Weiner J. Acute esophageal variceal sclerotherapy. JAMA 1986;255:497-500.
34. El-Zayadi A, El-Din S, Kabil M. Endoscopic scierotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointest Endosc 1988;34:314-317.
35. Alexandrino P, Alves MM, Fidalgo P, Matos L, Esteves AV, Veloso J, Oliveira AG, Moura MC. Is sclerotherapy the first choice treatment for active oesophageal variceal bleeding in cirrhotic patients? Final report of a randomized clinical trial. J Hepatol 1990;11(suppl):S1.
36. Hartigan PM, Gebhard RL, Gregory PB, Sclerotherapy for actively Veterans Affairs Cooperative Variceal Sclerotherapy Group. Sclerotherapy for actively bleeding oesophageal varices in male alcoholics with cirrhosis. Gastrointest Endosc 1997;46:1-7.
37. Arcidiacono R, Biraghi M, Bonomo M, Fiaccadori F. Randomized controlled trial with terlipressin in cirrhotic patients with bleeding oesophageal varices: effects on precocious rebleeding and mortality rate. Curr Ther Res 1992;52:185-195.
38. Primignani M, Andreoni B, Carpinelli L, Capria A, Rocchi G, Lorenzini I, Staudacher C, Beretta L, Motta R, de Franchis R. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 1995;21:1322-1327.
39. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P, Larricq J, Gourlaouen A, Ribard D, Kara MN, Legoux JL, Pillegand B, Becker MC, DiCostanzo J, Metreau JM, Silvain C, Beauchant M. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-560.
40. Brunati X, Ceriani R, Curioni R, Brunelli L, Repaci G, Morini L. Sclerotherapy alone vs sclerotherapy plus terlipressin versus sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage. Hepatology 1996;24:549-543.
41. Novella MT, Villanueva C, Ortiz J, Pamplona J, Sainz S, Soriano G, Torras X, Balanzò J. Octreotide vs sclerotherapy and octreotide for acute variceal bleeding. A pilot study. Hepatology 1996;24:207A (abstr).
42. Avguerinos A, Nevens F, Raptis S, Fevery J., Above Study Group. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding oesophageal variceal Episodes (Above) randomised trial. Lancet 1997;350:1495-1499.
43. Signorelii S, Paris B, Negrin F, Cesareni P, Minola E, Auriemma L. Octreotide and endoscopic variceal sclerotherapy in the management of acute variceal acute haemorrhage (abstr). Endoscopic 1999;31:E66.
44. Villanueva C, Ortiz J, Sabat M, Gaffego A, Torras X, Soriano G, Sainz S, Boadas J, Cussò X, Guarner C, Balanzò J. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute variceal bleeding: a prospective randomized trial. Hepatology 1999;30:384-389.
45. Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol 2000;95:768-771.
46. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D. French Club for the Study of Portal Hypertension. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23-28.
47. Westaby D, Hayes P, Gimson AES, Polson R, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989;9:274-277.
48. Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Banares R, Cales P, Pateron D, Bernard B, Vinel JP, Bosch J. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000;32:471-476.
49. Di Febo G, Siringo S, Vacirca M, Santoro M, Meriggi S, Mustafà A, Barbara L. Somatostatin and urgent sclerotherapy in active esophageal variceal bleeding. Gastroenterology 1990;98:A583 (abstr).
50. Shields R, Jenkins SA, Baxter JN, Kingsnorth AN, Ellenbogen S, Makin CA, Gilmore I, Morris AI, Ashby D, West CR. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of oesophageal varices. J Hepatol 1992;16:128-137.
51. Planas R, Quer JQ, Boix J, Canet J, Armengol M, Cabre E, Pintanel T, Humbert P, Oller B, Broggi MA, Gassul MA. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994;20:370-375.
52. Ramires R, Zils C, Mattos A. Escleroterapia versus somatostatina na hemorragia digestiva alta por ruptura de varizes esofagicas. Arq Gastroenterol 2000;37:148-154.
53. Sung JJ, Chung SCS, Lai CW, Chan FKL, Leung JWC, Yung MY, Kassianides C, Li AKC. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993;342:637-641.
54. Poo JL, Bosques S, Guarduno R, Marin E, Moran MA, Bobadilla J, Maldonado EP, Morales D, Garcia-Cantù D, Uribe M. Octreotide versus emergency sclerotherapy in acute variceal hemorrhage in liver cirrhosis. A randomized multicenter study. Gastroenterology 1996;110:A1297 (abstr).
55. Jenkins SA, Shields R, Davies M, Elias E, Turnbull AJ, Bassendine MF, James OFW, Iredale JP, Vyas SK, Arthur MJP, Kingsnorth AN, Sutton R. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal hemorrhage. Gut 1997;41:526-533.
56. Lopez F, Vargas R, Margarita G, Rizo T, Arguelles D. Octreotide vs sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1999;30:574A (abstr).
57. Bildozola M, Kravetz D, Argonz J, Romero G, Suarez A, Jmelnitzky A, Fainberg M, Fassio E, Berreta J, Romero G, Landeira G, Martinez H, Bosco A, Guevara M, Valero J, Chopita N, Berenstein G, Terg R. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicenter, and randomized clinical trial. Scand J Gastroenterol 2000;35:419-425.
58. Sivri B, Oksuzoglu G, Bayraktar Y, Kayhan B. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding. Hepatogastroenterology 2000;47:166-173.
59. Freitas SD, Sofia C, Pontes JM, Gregorio C, Cabral PJ, Andrade P, Rosa A, Camacho E, Ferriera M, Portela F, Romdozinho JM, Tomè L, Gouveia H, Leitao M, Pimenta I, Donato A. Octreotide in acute bleeding esophageal varices: a prospective randomized study. Hepatogastroenterology 2000;47:1310-1314.
60. Yousuf MH, Rauf AH, Baig IM, Akram M, Rizwan Z. Initial management of acute variceal haemorrhage. Comparison of octreotide and sclerotherapy. J Coll Phys Surg Pak 2000;10:95-97.
61. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
62. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 1995;123:280-287.
63. Gralnek IM, Jensen DM, G, Kovacs TO, Jutabha R, Machicado GA, Gornbein J, King J, Cheng S, Jensen ME. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50.
64. D'Amico G, Criscuoli V, Filì D, Mocciaro F, Pagliazo L. Meta-analysis of trial for variceal bleeding. Hepatology 2002;36:1023-1024.